In some cases, such conditions can be caused by rare, “monogenic” pathogenic variants that lead to a several-fold increased risk—important examples are pathogenic variants in LDLR that cause familial hypercholesterolemia and pathogenic variants in BRCA1 and BRCA2 that underlie hereditary breast and ovarian cancer syndrome. This evidence concerns the gene LDLR and familial hypercholesterolemia.